Drug Shortage Report for APO-TOPIRAMATE

Last updated on 2018-07-03 History
Report ID 48869
Drug Identification Number 02279614
Brand name APO-TOPIRAMATE
Common or Proper name TOPIRAMATE
Company Name APOTEX INC
Active Ingredient(s) TOPIRAMATE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-07
Estimated end date 2018-07-09
Actual end date 2018-06-29
Shortage status Resolved
Updated date 2018-07-03
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-07-03 French Compare
v3 2018-07-03 English Compare
v2 2018-05-08 French Compare
v1 2018-05-08 English Compare